HKSE - Delayed Quote HKD

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)

343.600
+7.600
+(2.26%)
As of 10:15:59 AM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,933,045
1,933,045
1,540,493
803,933
32,322
Cost of Revenue
659,388
659,388
781,308
276,828
20,525
Gross Profit
1,273,657
1,273,657
759,185
527,105
11,797
Operating Expense
1,485,059
1,485,059
1,211,799
921,033
807,128
Operating Income
-211,402
-211,402
-452,614
-393,928
-795,331
Net Non Operating Interest Income Expense
30,381
30,381
-39,123
-147,397
-111,785
Pretax Income
-142,545
-142,545
-467,692
-567,364
-889,795
Tax Provision
124,221
124,221
106,442
48,735
0
Net Income Common Stockholders
-266,766
-266,766
-522,209
-548,099
-889,795
Diluted NI Available to Com Stockholders
-266,766
-266,766
-522,209
-548,099
-889,795
Basic EPS
-0.84
-1.20
-2.84
-2.54
-4.12
Diluted EPS
-0.84
-1.20
-2.84
-2.54
-4.12
Basic Average Shares
222,844.099
221,647.585
183,629.180
215,828.599
215,828.599
Diluted Average Shares
222,844.099
221,647.585
183,629.180
215,828.599
215,828.599
Total Operating Income as Reported
-138,749
-138,749
-383,383
-418,550
-777,204
Total Expenses
2,144,447
2,144,447
1,993,107
1,197,861
827,653
Net Income from Continuing & Discontinued Operation
-266,766
-266,766
-574,134
-616,099
-889,795
Normalized Income
-283,672.790
-283,672.790
-581,279.550
-620,784.490
-890,149
Interest Income
34,177
34,177
45,186
1,417
806
Interest Expense
3,796
3,796
84,309
148,814
112,591
Net Interest Income
30,381
30,381
-39,123
-147,397
-111,785
EBIT
-138,749
-138,749
-383,383
-418,550
-777,204
EBITDA
-47,363
-47,363
-308,307
-351,186
-754,290
Reconciled Cost of Revenue
659,388
659,388
781,308
276,828
20,525
Reconciled Depreciation
91,386
91,386
75,076
67,364
22,914
Net Income from Continuing Operation Net Minority Interest
-266,766
-266,766
-574,134
-616,099
-889,795
Total Unusual Items Excluding Goodwill
21,401
21,401
9,045
5,931
354
Total Unusual Items
21,401
21,401
9,045
5,931
354
Normalized EBITDA
-68,764
-68,764
-317,352
-357,117
-754,644
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
4,494.210
4,494.210
1,899.450
1,245.510
0
12/31/2021 - 7/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

INCPF InnoCare Pharma Limited
3.2600
0.00%
 
33C.MU InnoCare Pharma Ltd
1.1900
+5.31%
 
6996.HK Antengene Corporation Limited
3.910
+5.11%
 
9606.HK Duality Biotherapeutics, Inc.
203.000
+1.50%
 
2696.HK Shanghai Henlius Biotech, Inc.
43.200
+6.54%
 
2410.HK TYK Medicines, Inc
22.900
+4.33%
 
2171.HK CARsgen Therapeutics Holdings Limited
21.700
+4.33%
 
2162.HK Keymed Biosciences Inc.
43.850
+4.90%
 
1801.HK INNOVENT BIO
57.200
+3.44%
 
1541.HK IMMUNEONCO-B
7.700
+2.53%